Intestinal dysbiosis in inflammatory bowel disease

Gut Microbes

Volumn 2, Issue 4, 2011, Pages

  Kaur, Nirmal ^a   Chen, Chun Chia ^b   Luther, Jay ^a   Kao, John Y ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Antibiotics; Dysbiosis; Inflammatory bowel disease; Microbiota; Probiotics

Indexed keywords

ANTIBIOTIC AGENT;

CLINICAL PRACTICE; CROHN DISEASE; ENTERITIS; EUROPE; HUMAN; MICROFLORA; MORBIDITY; NONHUMAN; PATHOGENESIS; REVIEW; ULCERATIVE COLITIS; UNITED STATES;

EID: 80054036384     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.2.4.17863     Document Type: Review

References (51)

1. Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011; 60:571-607; DOI:10.1136/ gut.2010.224154.
2. Khan KJ, Ullman TA, Ford AC, Abreu MT, Abadir A, Abadir A, et al. Antibiotic therapy in inflammatory bowel disease: a systematic review and metaanalysis. Am J Gastroenterol 2011; 106:661-73; DOI:10.1038/ajg.2011.72.
3. Thia KT, Loftus EV Jr, Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol 2008; 103:3167-82; DOI:10.1111/j.1572-0241.2008.02158.x.
4. Zheng JJ, Zhu XS, Huangfu Z, Gao ZX, Guo ZR, Wang Z. Crohn's disease in mainland China: a systematic analysis of 50 years of research. Chin J Dig Dis 2005; 6:175-81; DOI:10.1111/ j.1443-9573.2005.00227.x.
5. Desai HG, Gupte PA. Increasing incidence of Crohn's disease in India: is it related to improved sanitation? Indian J Gastroenterol 2005; 24:23-4
6. Colombel JF, Vernier-Massouille G, Cortot A, Gower- Rousseau C, Salomez JL. Epidemiology and risk factors of inflammatory bowel diseases. Bull Acad Natl Med 2007; 191:1105-18
7. Swidsinski A, Loening-Baucke V, Verstraelen H, Osowska S, Doerffel Y. Biostructure of fecal microbiota in healthy subjects and patients with chronic idiopathic diarrhea. Gastroenterology 2008; 135:568-79; DOI:10.1053/j.gastro.2008.04.017.
8. Zoppi G, Cinquetti M, Luciano A, Benini A, Muner A, Bertazzoni Minelli E. The intestinal ecosystem in chronic functional constipation. Acta paediatrica 1998; 87:836-41.
9. Kassinen A, Krogius-Kurikka L, Makivuokko H, Rinttila T, Paulin L, Corander J, et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007; 133:24-33; DOI:10.1053/j. gastro.2007.04.005.
10. Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP, Letulle S, Langella P, et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS ONE 2011; 6:16393; DOI:10.1371/journal. pone.0016393.
11. Bhonchal S, Nain CK, Taneja N, Sharma M, Sharma AK, Sinha SK, Singh K. Modification of small bowel microflora in chronic alcoholics with alcoholic liver disease. Tropical Gastroenterology 2007; 28:64-6.
12. Xu M, Wang B, Fu Y, Chen Y, Yang F, Lu H, et al. Changes of Fecal Bifidobacterium Species in Adult Patients with Hepatitis B Virus-Induced Chronic Liver Disease. Microb Ecol 2011; In press.
13. Pineton de Chambrun G, Colombel JF, Poulain D, Darfeuille-Michaud A. Pathogenic agents in inflammatory bowel diseases. Curr Opin Gastroenterol 2008; 24:440-7; DOI:10.1097/ MOG.0b013e3283023be5.
14. Reiff C, Kelly D. Inflammatory bowel disease, gut bacteria and probiotic therapy. Int J Med Microbiol 2010; 300:25-33; DOI:10.1016/j. ijmm.2009.08.004.
15. Gerritsen J, Smidt H, Rijkers GT, de Vos WM. Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr 2011; 6:209-40; DOI:10.1007/s12263-011-0229-7.
16. Vanderpool C, Yan F, Polk DB. Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases. Inflamm Bowel Dis 2008; 14:1585-96; DOI:10.1002/ ibd.20525.
17. Schultz M. Clinical use of E. coli Nissle 1917 in inflammatory bowel disease. Inflammatory Bowel Dis 2008.
18. Triantafillidis JK, Merikas E, Georgopoulos F. Current and emerging drugs for the treatment of inflammatory bowel disease. Drug Des Devel Ther 2011; 5:185-210.
19. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 1998; 66:5224-31
20. Waidmann M, Bechtold O, Frick JS, Lehr HA, Schubert S, Dobrindt U, et al. Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice. Gastroenterology 2003; 125:162-77; DOI:10.1016/ S0016-5085(03)00672-3.
21. Chichlowski M, Sharp JM, Vanderford DA, Myles MH, Hale LP. Helicobacter typhlonius and Helicobacter rodentium differentially affect the severity of colon inflammation and inflammation-associated neoplasia in IL10-deficient mice. Comp Med 2008; 58:534-41
22. Grassl GA, Valdez Y, Bergstrom KSB, Vallance BA, Finlay BB. Chronic enteric salmonella infection in mice leads to severe and persistent intestinal fibrosis. Gastroenterology 2008; 134:768-80; DOI:10.1053/j.gastro.2007.12.043.
23. Sitaraman SV, Klapproth JM, Moore DA, Landers C, Targan S, Williams IR, et al. Elevated flagellinspecific immunoglobulins in Crohn's disease. Am J Physiol Gastrointest Liver Physiol 2005; 288:403-6; DOI:10.1152/ajpgi.00357.2004.
24. Himmel ME, Hardenberg G, Piccirillo CA, Steiner TS, Levings MK. The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease. Immunology 2008; 125:145-53; DOI:10.1111/j.1365-2567.2008.02939.x.
25. Takaishi H, Matsuki T, Nakazawa A, Takada T, Kado S, Asahara T, et al. Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. International journal of medical microbiology. Int J Med Microbiol 2008; 298:463-72; DOI:10.1016/j. ijmm.2007.07.016.
26. Walker AW, Sanderson JD, Churcher C, Parkes GC, Hudspith BN, Rayment N, et al. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol 2011; 11:7; DOI:10.1186/1471-2180-11-7.
27. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008; 453:620-5; DOI:10.1038/nature07008.
28. Willing B, Halfvarson J, Dicksved J, Rosenquist M, Järnerot G, Engstrand L, et al. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis 2009; 15:653-60; DOI:10.1002/ ibd.20783.
29. Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, Zheng Z, et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010; 139:1844-54
30. Conte MP, Schippa S, Zamboni I, Penta M, Chiarini F, Seganti L, et al. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut 2006; 55:1760-7; DOI:10.1136/gut.2005.078824.
31. Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Fölsch UR, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004; 53:685-93; DOI:10.1136/ gut.2003.025403.
32. Swidsinski A, Loening-Baucke V, Vaneechoutte M, Doerffel Y. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm Bowel Dis 2008; 14:147-61; DOI:10.1002/ ibd.20330.
33. Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, Singh R, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004; 127:80-93; DOI:10.1053/j.gastro.2004.03.054.
34. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004; 127:412-21; DOI:10.1053/j.gastro. 2004.04.061.
35. Sasaki M, Sitaraman SV, Babbin BA, Gerner-Smidt P, Ribot EM, Garrett N, et al. Invasive Escherichia coli are a feature of Crohn's disease. Laboratory Investigation 2007; 87:1042-54.
36. Komanduri S, Gillevet PM, Sikaroodi M, Mutlu E, Keshavarzian A. Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation. Clinical Gastroenterology and Hepatology 2007; 5:352-60.
37. Ruseler-van Embden JG, Schouten WR, van Lieshout LM. Pouchitis: result of microbial imbalance? Gut 1994; 35:658-64; DOI:10.1136/ gut.35.5.658.
38. Joossens M, Huys G, Cnockaert M, De Preter V, Verbeke K, Rutgeerts P, et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 2011; 60:631-7; DOI:10.1136/gut.2010.223263.
39. Prindiville T, Cantrell M, Wilson KH. Ribosomal DNA sequence analysis of mucosa-associated bacteria in Crohn's disease. Inflamm Bowel Dis 2004; 10:824-33; DOI:10.1097/00054725-200411000-00017.
40. Seksik P, Lepage P, de la Cochetière MF, Bourreille A, Sutren M, Galmiche JP, et al. Search for localized dysbiosis in Crohn's disease ulcerations by temporal temperature gradient gel electrophoresis of 16S rRNA. J Clin Microbiol 2005; 43:4654-8; DOI:10.1128/JCM.43.9.4654-8.2005.
41. Zhang M, Liu B, Zhang Y, Wei H, Lei Y, Zhao L. Structural shifts of mucosa-associated lactobacilli and Clostridium leptum subgroup in patients with ulcerative colitis. J Clin Microbiol 2007; 45:496-500; DOI:10.1128/JCM.01720-06.
42. Kanareykina SK, Misautova AA, Zlatkina AR, Levina EN. Proteus dysbioses in patients with ulcerative colitis. Nahrung 1987; 31:557-61; DOI:10.1002/food.19870310570.
43. Sun L, Nava GM, Stappenbeck TS. Host genetic susceptibility, dysbiosis and viral triggers in inflammatory bowel disease. Curr Opin Gastroenterol 2011; 27:321-7; DOI:10.1097/ MOG.0b013e32834661b4.
44. Noverr MC, Huffnagle GB. The 'microflora hypothesis' of allergic diseases. Clinical and Experimental Allergy 2005; 35:1511-20.
45. López-Serrano P, Pérez-Calle JL, Pérez-Fernández MT, Fernández-Font JM, Boixeda de Miguel D, Fernández- Rodríguez CM. Environmental risk factors in inflammatory bowel diseases. Investigating the hygiene hypothesis: a Spanish case-control study. Scand J Gastroenterol 2010; 45:1464-71; DOI:10.3109/00365521.2010.510575.
46. Koloski NA, Bret L, Radford-Smith G. Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature. World J Gastroenterol 2008; 14:165-73; DOI:10.3748/ wjg.14.165.
47. Luther J, Dave M, Higgins PD, Kao JY. Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflamm Bowel Dis 2010; 16:1077-84
48. Korzenik JR. Past and current theories of etiology of IBD: toothpaste, worms and refrigerators. J Clin Gastroenterol 2005; 39:59-65; DOI:10.1097/01.mcg.0000155553.28348.fc.
49. Swartz MN. Human Health Risks With the Subtherapeutic Use of Penicillin or Tetracyclines in Animal Feed. National Academy Press 1989.
50. Mellon MBC, Benbrook KL. Union of Concerned Scientists 2001.
51. Shea KM. Antibiotic resistance: what is the impact of agricultural uses of antibiotics on children's health? Pediatrics 2003; 112:253-8